Prevalence of Oxaliplatin-induced Chronic Neuropathy and Influencing Factors in Patients with Colorectal Cancer in Iran
作者： Ali Shahriari-Ahmadi , Ali Fahimi , Mehrdad Payandeh , Masoud Sadeghi
DOI: 10.7314/APJCP.2015.16.17.7603
关键词:
摘要: … , severity of anemia in patients with neuropathy compared to those without. Conclusions: Oxaliplatin regimens can induce chronic neuropathy in CRC patients, with anemia, high BMI …
iums.ac.ir
koreascience.or.kr参考文章(26)
O Kyriakopoulou, V Zolota, A A Argyriou, H P Kalofonos, Toxic peripheral neuropathy associated with commonly used chemotherapeutic agents. Journal of B.U.ON. : official journal of the Balkan Union of Oncology. ,vol. 15, pp. 435- 446 ,(2010)
順子 岩崎, 敦 大津, Oxaliplatin,fluorouracil,and leucovorin as adjuvant treatment for colon cancer.Andre T,et al.for Multicenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC) Investigators.N Engl J Med 2004;350:2343-51.PMID:15175436--大腸癌の術後補助化学療法で、初めて多剤併用療法の優越性を証明した注目すべき試験 Mebio oncology. ,vol. 1, pp. 100- 102 ,(2004)
Naoyuki Chisato, Yoshiaki Ebisawa, Hidenori Karasaki, Kazuo Matsubara, Hiroyuki Furukawa, Toru Kono, Toshiyuki Asama, Machiko Satomi, Manabu Suno, Cetuximab-induced hypomagnesaemia aggravates peripheral sensory neurotoxicity caused by oxaliplatin. Journal of gastrointestinal oncology. ,vol. 1, pp. 97- 101 ,(2010) , 10.3978/J.ISSN.2078-6891.2010.024
Moghimi-Dehkordi B, Pourhoseingholi Ma, Zali Mr, Fatem, Ghiasi S, Azadeh S, Colorectal cancer in Iran: an epidemiological study. Asian Pacific Journal of Cancer Prevention. ,vol. 9, pp. 123- 126 ,(2008)
Kyung Kee Baek, Jeeyun Lee, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Yong Beom Cho, Seong Hyeon Yun, Hee Cheol Kim, Woo Yong Lee, Ho-Kyung Chun, None, Oxaliplatin-induced chronic peripheral neurotoxicity: a prospective analysis in patients with colorectal cancer. Cancer Research and Treatment. ,vol. 42, pp. 185- 190 ,(2010) , 10.4143/CRT.2010.42.4.185
Erick Gamelin, Laurence Gamelin, Laura Bossi, Stefan Quasthoff, Clinical aspects and molecular basis of oxaliplatin neurotoxicity: Current management and development of preventive measures Seminars in Oncology. ,vol. 29, pp. 21- 33 ,(2002) , 10.1016/S0093-7754(02)90017-5
M Wasif Saif, Richard H Wilson, Nancy Harold, Bruce Keith, David S Dougherty, Jean L Grem, Peripheral neuropathy associated with weekly oral 5-fluorouracil, leucovorin and eniluracil. Anti-Cancer Drugs. ,vol. 12, pp. 525- 531 ,(2001) , 10.1097/00001813-200107000-00006
Andreas A. Argyriou, Panagiotis Polychronopoulos, Gregoris Iconomou, Angelos Koutras, Thomas Makatsoris, Miltiadis K. Gerolymos, Philippos Gourzis, Konstantinos Assimakopoulos, Haralabos P. Kalofonos, Elisabeth Chroni, Incidence and characteristics of peripheral neuropathy during oxaliplatin-based chemotherapy for metastatic colon cancer Acta Oncologica. ,vol. 46, pp. 1131- 1137 ,(2007) , 10.1080/02841860701355055
J Cassidy, S Clarke, E Díaz-Rubio, W Scheithauer, A Figer, R Wong, S Koski, K Rittweger, F Gilberg, L Saltz, XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results British Journal of Cancer. ,vol. 105, pp. 58- 64 ,(2011) , 10.1038/BJC.2011.201
Linh M. Alejandro, Carolyn E. Behrendt, Kim Chen, Harry Openshaw, Stephen Shibata, Predicting acute and persistent neuropathy associated with oxaliplatin. American Journal of Clinical Oncology. ,vol. 36, pp. 331- 337 ,(2013) , 10.1097/COC.0B013E318246B50D